DEBIAGGI, MAURIZIA
 Distribuzione geografica
Continente #
NA - Nord America 1.597
EU - Europa 1.090
AS - Asia 707
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 3.401
Nazione #
US - Stati Uniti d'America 1.591
CN - Cina 691
IE - Irlanda 326
UA - Ucraina 241
FI - Finlandia 150
DE - Germania 124
SE - Svezia 83
IT - Italia 52
GB - Regno Unito 44
FR - Francia 37
BE - Belgio 16
IN - India 7
CA - Canada 6
RU - Federazione Russa 6
IR - Iran 5
PL - Polonia 5
EU - Europa 4
NL - Olanda 4
AU - Australia 1
BO - Bolivia 1
DK - Danimarca 1
HK - Hong Kong 1
IQ - Iraq 1
JP - Giappone 1
MD - Moldavia 1
MU - Mauritius 1
TW - Taiwan 1
Totale 3.401
Città #
Ashburn 345
Chandler 330
Dublin 326
Jacksonville 279
Nanjing 206
Beijing 82
Nanchang 75
Shenyang 67
Princeton 64
Lawrence 57
Changsha 55
Ann Arbor 52
Hebei 52
Medford 48
Wilmington 41
Helsinki 38
Boardman 37
Jiaxing 34
Hangzhou 29
Tianjin 27
Shanghai 22
Woodbridge 19
Milan 18
Brussels 15
Los Angeles 10
Norwalk 9
Verona 9
Pavia 8
Auburn Hills 7
Fairfield 7
Jinan 6
Washington 6
Genoa 5
Toronto 5
Zhengzhou 5
Des Moines 4
Kunming 4
Poznan 4
Seattle 4
Guangzhou 3
Haikou 3
Lanzhou 3
Ningbo 3
Pune 3
Berlin 2
Bologna 2
Borås 2
Dearborn 2
Leawood 2
New York 2
Sacramento 2
Tappahannock 2
Zanjan 2
Andover 1
Baghdad 1
Bloomfield 1
Canberra 1
Central 1
Changchun 1
Chapel Hill 1
Chicago 1
Chisinau 1
Chongqing 1
Cuers 1
Dallas 1
Falkenstein 1
Henderson 1
Jinhua 1
Karby 1
Kashan 1
Kemerovo 1
London 1
Moscow 1
Norman 1
Novokuznetsk 1
Orange 1
Ottawa 1
Piscataway 1
Redmond 1
Rockville 1
Rome 1
San Francisco 1
San Giorgio A Cremano 1
Santa Clara 1
Taipei 1
Taiyuan 1
Tomsk 1
Udine 1
Zgierz 1
Totale 2.480
Nome #
Attività in vitro di nuovi chinoloni nei confronti di stafilococchi meticillino-resistenti: valutazione comparativa su stipiti di vecchio e recente isolamento. 290
Effects of propolis flavonoids on virus infectivity and replication. 98
AGGRESSIVE INTERFERON THERAPY IN HIV-HCV COINFECTED PATIENTS 91
Factors associated with nucleic acids related to human immunodeficiency virus type 1 in cervico-vaginal secretions. 85
Mice and rabbits: Animal models for HIV-1 infection 78
Human immunodeficiency virus type 1-related nucleic acid and papillomavirus DNA in cervicovaginal secretions of immunodefciency virus-infected women. 72
Biofilm formation and aggregative adherence of beta-lactamase producing Proteus mirabilis clinical isolates in Italy 72
Booster PCR: evaluation of an improved method for amplification of a few HIV-1 proviral DNA sequences 70
Bovine leukemia virus inhibiting activity in fetal calf serum. 70
Beta-lactam resistant Pseudomonas aeruginosa strains emerging during therapy: synergistic resistance mechanisms. 69
Tipizzazione mediante immunoblotting di Stafilococchi meticillino-resistenti di isolamento clinico 69
Severe recurrent myelitis in patients with hepatitis C virus infection 68
HCV-VIRAL KINETICS IN DIFFERENT CATEGORIES OF PATIENTS: DAILY VERSUS BID INDUCTION INTERFERON THERAPY 65
Antiviral activity of Chamaecyparis lawsoniana extract: study with herpes simplex virus type 2. 65
Emergence of cross-resistance to imipenem and other beta-lactam antibiotics in Pseudomonas aeruginosa during therapy. 64
Distinct mutational drug resistance profiles of HIV-1 RNA in plasma in culture isolates of patients receiving antiretroviral theraphy 62
Influence of lingual bracket position on microbial and periodontal parameters in vivo. 62
Monitoraggio delle resistenze ai chemioantibiotici in Pseudomonas mediante sistemi computerizzati 60
Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users 58
Third-generation cephalosporins resistance in clinical isolates of Enterobacteriaceae. 58
A promising cultural-biomolecular method for rapid isolation and identification of mycobacteria 58
Severe recurrent myelitis in patients with hepatitis C virus infection patients 57
Evaluation of aggregative adherence and biofilm formation in beta-lactamase producing Proteus mirabilis isolates from different clinical settings in Italy 57
Transfusion-transmitted virus infection in HIV-1-seropositive patients 57
Molecular epidemiology of KI and WU polyomaviruses in infants with acute respiratory disease and in adult hematopoietic stem cell transplant recipients. 57
Preliminary characterization of an inhibitory activity of fetal bovine serum on the infectivity of rotavirus strain SA-11. 57
"In vitro" studies on susceptibility and resistance of clinical Chlamydia tracomathis strains 55
Prolonged human metapneumovirus infection in adult patients after allogenic haemopoietic stem cell transplantion 54
Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy 53
Long-term study on symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients. 53
Quantitative assessment of cell-associated and cell-free virus in cervicovaginal samples of HIV-1-infected women 51
HIV type 1 intraperitoneal infection of rabbits permits early detection of serum antibodies to Gag, Pol, and Env proteins, neutralizing antibodies, and proviral DNA from peripheral blood mononuclear cells 51
The role of infections and coinfections with newly identified and emerging respiratory viruses in children 51
Studio prospettico sulle infezioni e coinfezioni da virus respiratorio sinciziale e virus di recente identificazione in età pediatrica. 50
INFEZIONE DA METAPNEUMOVIRUS IN SOGGETTI SOTTOPOSTI A TRAPIANTO DI CELLULE STAMINALI EMOPOIETICHE 50
Modifications of DNA-gyrase and of permeability in a norfloxacin-resistant clinical isolate of Providencia stuartii. 50
Daily Interferon therapy in HIV-HCV coinfected patients: Preliminary Report 50
Viral excretion in the cervicovaginal secretions of HIV-1 infected women receiving antiretroviral therapy. 49
Two-year prospective study of single infections and co-infections by respiratory syncytial virus and viruses identified recently in infants with acute respiratory disease. 49
Dissemination of a CMY-16 producing clone of P. mirabilis in long-term care and rehabilitation facilities of northern Italy 49
Differences in biofilm formation and aggregative adherence between beta-lactam susceptible and beta-lactamases producing P. mirabilis clinical isolates. 49
Persistent symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients. 48
Immunoblot typing of oxacillin-resistant Staphylococcus aureus clinical isolates. 47
Emergence of a VIM-1 MBL and CTX-M-15 ESbL-producing Klebsiella pneumoniae clone from acute and rehabilitation hospitals in Italy. 47
Long-term study on symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients 45
Epidemiological, molecular and clinical features of Enterovirus 109 infection in children and in adult stem cell transplant recipients. 45
Valutazione comparativa della crescita di Metapneumovirus umano su differenti linee cellulari 44
Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy 44
Prevalence and histologic features of transfusion transmitted virus and hepatitis C virus coinfection in a group of HIV patients 43
Human metapneumovirus infection in adult patients after allogenic hemopoietic stem cell transplantion 43
Modification of norfloxacin inhibition of DNA gyrase induced by a 28 KDal DNA binding protein. 43
CARDIOLOGIA NELL'AIDS 41
Dominant role of host selective pressure in driving hepatitis C virus evolution in perinatal infection 40
Prevalence of the newly described human enterovirus 109 in infants with acute respiratory disease in Italy 39
Norfloxacin resistance in Providencia stuartii: modifications in DNA-gyrase and permeability. 38
Occurrence of antipseudomonal beta-lactams and aminoglycosides resistance in Pseudomonas aeruginosa during therapy. 35
Epidemiological, molecular and clinical features of enterovirus 109 infection in children and in adult stem cell transplant recipients 28
Studio dell'infezione da Metapneumovirus in pazienti adulti sottoposti a trapianto allogenico di cellule staminali emopoietiche 22
Totale 3.425
Categoria #
all - tutte 10.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.105


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 0 2 7
2019/2020842 227 322 1 46 3 50 8 49 4 69 62 1
2020/2021429 52 41 13 47 2 61 4 61 12 63 61 12
2021/2022252 5 2 4 2 3 3 6 12 13 9 52 141
2022/2023941 92 86 5 74 100 101 0 56 388 8 24 7
2023/2024522 39 45 19 22 23 99 11 244 4 12 4 0
Totale 3.425